Treefrog Therapeutics
FranceEntry
2019
Hold
7yr
Status
Active
Who owns Treefrog Therapeutics?
Treefrog Therapeutics is a French Biotech company, currently owned by Galia Gestion since 2019 and 2 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Galia GestionGalia Investissements IV · 2020
3 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2018 · present
Aquiti GestionActive
2018 · present(8yr) · ACI (Aquitaine Creation Investissement) · 2010 · VC
Galia GestionActive
2019 · present(7yr) · Galia Investissements IV · 2020
More from Galia Investissements IV
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Treefrog Therapeutics?
Treefrog Therapeutics is currently owned by Galia Gestion, Aquiti Gestion and 1 other, through Galia Investissements IV, since 2019.
When did Galia Gestion and 2 others acquire Treefrog Therapeutics?
Galia Gestion and 2 others acquired Treefrog Therapeutics in 2019.
Who has owned Treefrog Therapeutics over time?
Treefrog Therapeutics has been through 3 private-equity ownership periods: Aquiti Gestion · via ACI (Aquitaine Creation Investissement) · since 2018; Irdi Capital-Investissement · via IRDInov 2 · since 2018; Galia Gestion · via Galia Investissements IV · since 2019.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue